Musaffa Logo
Aurobindo Pharma Ltd AUROPHARMA.NS

Last Updated: Jul 21, 12:00 AM·NSE

AUROPHARMA.NS Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Aurobindo Pharma Ltd is classified as halal.

HALAL

Report Source: 2026 Annual Report

Aurobindo Pharma Ltd

Aurobindo Pharma Ltd. Stock Analysis AUROPHARMA.NS

India Health Care Mid Cap Report:
Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. The firm is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, branded pharmaceuticals, generic pharmaceuticals, and related services. Its key therapeutic segments include Central nervous systems (CNS), Antiretrovirals (ARVs), Cardiovascular (CVS), SSP - Orals and Sterile, Anti-infectives, Anti-diabetics and Cephalosporins - Orals. The company is engaged in developing a range of oncology, non-oncology prescription formulation, and hormonal products. The company is developing topical as well as transdermal products in the dermatology therapeutic segment. The company is marketing its products globally in approximately 150 countries. Its subsidiaries include APL Healthcare Limited, Auronext Pharma Private Limited, Auro Peptides Limited, APL Pharma Thai Limited, Auro Pharma Inc, Aurobindo Pharma (Malta) Limited, APL Swift Services (Malta) Limited, Aurobindo Pharma Industria Farmaceutica Ltd, and others.
Read More

Aurobindo Pharma Ltd (AUROPHARMA.NS) Chart

Key Statistics of Aurobindo Pharma Ltd (AUROPHARMA.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹1,547.30₹1,584.80

Today's Open

₹1,567.00

Volume

539.94K

P/E Ratio (TTM)

25.95

52 Week Range

₹1,016.10₹1,636.80

Market Cap

910.82B

Avg. Volume

1.20M

Dividend Yield

0.26%

Financial Metrics & Statements of Aurobindo Pharma Ltd (AUROPHARMA.NS)

Super Investors Invested in Aurobindo Pharma Ltd (AUROPHARMA.NS)

FAQ's for Aurobindo Pharma Ltd (AUROPHARMA.NS)

  • As of July 2026, Aurobindo Pharma Ltd AUROPHARMA.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Aurobindo Pharma Ltd using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Aurobindo Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Aurobindo Pharma Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Aurobindo Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Aurobindo Pharma Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.